Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Montrium Releases Office 365 Compliance Toolkits to Accelerate Transition to Cloud for the Life Sciences

    Nov 18, 2019, 07:56 AM by Michael Croft
    MONTREAL, QC, CANADA - Nov 20, 2019 - Montrium, an experienced and trusted technology consulting company for the life sciences industry, today announced the launch of a series of comprehensive service Toolkits to support migrating and managing regulated content in Microsoft’s Office 365 platform
    Full story
  • Survey Findings Show Increase in Clinical Trial Results Transparency

    Nov 15, 2019, 11:46 AM by Michael Croft
    JERSEY CITY, NJ, UNITED STATES - Nov 15, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has released results from its 2nd Biennial Plain Language Summaries (PLS) Survey
    Full story
  • Lifebit and Medley Genomics Partner to Deliver Streamlined Solution Supporting New Diagnostic and Therapeutic Discoveries

    Nov 14, 2019, 08:13 AM by Michael Croft
    LONDON, UK - Nov 14, 2019 -
    Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, and Medley Genomics, a company focused on using advanced data analytics to support better diagnosis and treatment of complex diseases, announced today their partnership agreement
    Full story
  • Oxford Nanopore Develops Pore-C, Couples Chromatin Conformation Capture With Long Read Tech

    Nov 14, 2019, 07:45 AM by Michael Croft

    Bio-IT World News Brief | Last week Weill Cornell Medicine and Oxford Nanopore published a pre-print describing Pore-C, a new nanopore sequencing technique which couples chromatin conformation capture with Oxford Nanopore Technologies long reads to directly sequence multi-way chromatin contacts without amplification.

    Full story
  • Creative Diagnostics Introduces New Foodborne Pathogen Antibodies and Antigens

    Nov 14, 2019, 03:21 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Nov 14, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics launches a large range of foodborne pathogen antibodies and antigens, which have been validated to work in various types of immunoassays and can be supplied as high quality tools for the detection of foodborne pathogens
    Full story
  • MeMed Wins €2.5M Award from European Innovation Council

    Nov 13, 2019, 14:58 PM by Michael Croft
    HAIFA, ISRAEL - Nov 13, 2019 -  MeMed Ltd., a leader in host response-based diagnostic solutions, today announced that it has received €2
    Full story
  • Baystate Health and Life Image Announce Strategic Partnership to Develop AI Innovations to Improve Treatment Decisions and Match Cancer Patients to Clinical Trials

    Nov 13, 2019, 11:09 AM by Michael Croft
    BOSTON & SPRINGFIELD, MA, UNITED STATES - Nov 12, 2019 -   Baystate Health, the premier integrated health system serving more than 800,000 patients in western New England, announced a strategic partnership with Life Image, the largest medical evidence network providing access to points of care and curated clinical and imaging data, to develop novel artificial intelligence tools that would help advance technical innovations in radiology, neurology and oncology
    Full story
  • LG Chem Life Sciences Expands Partnership with Avacta Group plc

    Nov 13, 2019, 10:32 AM by Michael Croft
    CAMBRIDGE, UK, UNITED KINGDOM - Nov 13, 2019 -  Avacta Group plc (AIM:AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to provide an update on the Affimer therapeutics development partnership and license agreement with LG Chem Life Sciences (LG Chem), part of the South Korean LG Group, to develop Affimer therapeutics in several disease areas
    Full story
  • Turbine secures €3 million EUR seed fund to expand the potential of simulation-first drug discovery

    Nov 13, 2019, 10:30 AM by Michael Croft
    LONDON, UK & BUDAPEST, HUNGARY - Nov 13, 2019 - Turbine, a simulation-based drug discovery company today announced the closing of an institutional financing round led by Delin Ventures
    Full story
  • Tumor Organoids For High-Throughput Drug Screening

    Nov 13, 2019, 07:20 AM by Michael Croft

    Bio-IT World | Interest is growing among oncology researchers in using tumor organoids to mimic cancer characteristics and drug responses in humans.

    Full story
  • X4 Pharmaceuticals Receives Breakthrough Therapy Designation from the FDA for Mavorixafor for the Treatment of WHIM Syndrome

    Nov 12, 2019, 09:35 AM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Nov 12, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced that the U
    Full story
  • Lifebit Announces General Release of its Federated Genomics Cloud Operating System

    Nov 8, 2019, 10:53 AM by Michael Croft
    LONDON, UK - Nov 7, 2019 - Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, announced today the general release of Lifebit CloudOS
    Full story
  • OptraHEALTH, InformedDNA Partner To Expand Access To Genetics Experts

    Nov 8, 2019, 09:20 AM by Michael Croft

    Bio-IT World News Brief | OptraHEALTH and InformedDNA today announced that they will partner to offer access to InformedDNA’s board-certified genetic counselors through GeneFAX’s AI-enabled CounselorConnect platform.

    Full story
  • UKI2S wins Best Sector Support Organisation at the OBN Awards

    Nov 8, 2019, 05:51 AM by Michael Croft
    LONDON, UK - Nov 8, 2019 - UK Innovation & Science Seed Fund (UKI2S) is delighted to announce it is has been awarded ‘Best Sector Support Organisation’ at the 11th Annual OBN Awards celebration last night
    Full story
  • Signant Health Host 8th Annual eCOA Forum To Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology

    Nov 7, 2019, 11:42 AM by Michael Croft
    PHILADELPHIA, PA - Nov 7, 2019 - Signant Health is proud to host its 8th annual eCOA Forum, which convenes clinical operations and outcomes research leaders for the industry’s premier event focused on eCOA, eConsent, and patient-centric technology
    Full story
  • Signant Health Proud to Sponsor the Philadelphia Walk to End Alzheimer’s in Nationwide Effort to Build Awareness, Raise Funds and Advance Research Towards a Cure.

    Nov 7, 2019, 09:04 AM by Michael Croft
    PHILADELPHIA, PA - Nov 7, 2019 - Signant Health, formerly CRF Health and Bracket, announced today that it is sponsoring the Philadelphia Walk to End Alzheimer’s
    Full story
  • Healthy Gut Microbiome Reference Database Initiated

    Nov 6, 2019, 06:30 AM by Michael Croft

    Bio-IT World | A group of researchers describe an initial baseline healthy gut microbiome reference database and put forth a prototype reporting template. The goal behind the work is to map the healthy gut microbiome so that they and other researchers can use the data to develop disease-specific prediction models.

    Full story
  • X4 Pharmaceuticals Initiates Phase 1b Clinical Trial of Mavorixafor for the Treatment of Severe Congenital Neutropenia

    Nov 5, 2019, 10:16 AM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Nov 5, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of a Phase 1b clinical trial of mavorixafor (X4P-001) for the treatment of Severe Congenital Neutropenia (SCN), a group of rare blood disorders characterized by abnormally low levels of neutrophils
    Full story
  • Microway Showcases NVIDIA® DGX-2™ AI System at GTC DC 2019

    Nov 4, 2019, 13:12 PM by Michael Croft
    PLYMOUTH, MA, UNITED STATES - Nov 4, 2019 - Microway, a leading provider of computational clusters, servers, and workstations for HPC and AI, announces the NVIDIA® DGX-2™  system will be showcased in Microway’s booth at the GPU Technology Conference 2019, November 4th – 6th in Washington, D
    Full story
  • LetsGetChecked Appoints Leading Healthcare Innovator Sasha Khursheed Said as Senior Vice President of Revenue

    Nov 4, 2019, 12:48 PM by Michael Croft
    NEW YORK, NY, UNITED STATES - Nov 5, 2019 - New York - LetsGetChecked, a leading direct-to-consumer at-home health testing company, today announced the appointment of Sasha Khursheed Said as Senior Vice President of Revenue
    Full story
  • «
  • 221 (current)
  • 222
  • 223
  • 224
  • 225
  • 226
  • 227
  • 228
  • 229
  • 230
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy